Q1 2023 Relmada Therapeutics Inc Earnings Call Transcript
Good afternoon. Thank you for attending today's Relmada Therapeutics, Inc. First Quarter 2023 Earnings Call. My name is (inaudible), and I will be your moderator for today's call. (Operator Instructions) It is now my pleasure to pass the conference over to our host, Tim McCarthy from LifeSci Advisors. Mr. McCarthy, please proceed.
Thank you, operator, and thank you all for joining us this afternoon. With me on today's call are Chief Executive Officer, Sergio Traversa, Chief Medical Officer, Dr. Cedric O'Gorman, and Chief Financial Officer, Maged Shenouda. This afternoon, Relmada issued a press release providing a business update announcing financial results for the 3 months ended March 31, 2023.
Please note that certain information discussed on the call today is covered under the safe harbor provisions of the Private Securities Litigation Reform Act. We caution listeners that during this call Relmada's management team will be making forward-looking statements. Actual results could
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |